|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Best Medical International, Inc., a developer of radiation products for the oncology, urology, neurology and gynecology markets. |
|---|---|
| Transferring Party | Vascular Brachytherapy (VBT) business of Novoste Corporation (NASDAQ:NOVT), a leader in products for vascular brachytherapy - radiation therapy delivered inside a blood vessel to prevent its reclosure (restenosis) following catheter-based interventional procedures. |
| Sector | Medical Devices |
| Date | August 25, 2005 |
| Analysis As per this asset purchase agreement, Best re-enters the VBT market with the last remaining independent VBT on the market. (Cordis/J&J and Guidant also offer VBT systems.) Best will market the Novoste VBT product line to existing Novoste customers and new cardiology accounts garnered by Best. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |